Product Information

CARBAMAZEPINE ER 200 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3794 per EA under NDC 16571068101. Its NADAC has been published 310 times since Dec 9, 2020.

FDA first approved this application on Apr 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 200 MG TABLET

CARBAMAZEPINE
$0.3794per EA

Strength

200 mg/1

NDC

16571068101

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211623

FDA Approved

4/24/2020

TE Code

AB

On Market Since

4/24/2020

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 200 MG TABLET has been published 310 times since Dec 9, 2020, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3794 per EA
All-time high$1.2670 (Dec 16, 2020)
All-time low$0.2489 (Nov 20, 2024)
52-week high$0.4126
52-week low$0.3488
Median price$0.5788
Average price$0.6463
Largest weekly change+79.9% (Jun 19, 2024)
Weeks tracked310
Tracking sinceDec 9, 2020

Price History

1W

0.0%

1M

-4.9%

3M

+2.9%

6M

-7.1%

1Y

+4.3%

3Y

-29.0%

5Y

-62.8%

All

-70.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 200 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3794 per EA (NDC 16571068101), effective Nov 11, 2026.

How has the price of CARBAMAZEPINE ER 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has declined 70.1%. It has been tracked across 310 weekly CMS publications since Dec 9, 2020.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 200 MG TABLET?

Since Dec 9, 2020, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has ranged from a low of $0.2489 (Nov 20, 2024) to a high of $1.2670 (Dec 16, 2020), with a median of $0.5788 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 200 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE 200 MG TABLET, is $0.1193 per EA — about 69% below CARBAMAZEPINE ER 200 MG TABLET.

Who manufactures CARBAMAZEPINE ER 200 MG TABLET?

CARBAMAZEPINE ER 200 MG TABLET (NDC 16571068101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.